Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1

被引:36
作者
Fang, Jin [1 ]
Bao, Yang-Yang [2 ]
Zhou, Shui-Hong [2 ]
Fan, Jun [3 ]
机构
[1] Second Hosp Jiaxing City, Dept Otolaryngol, Jiaxing 314000, Zhejiang, Peoples R China
[2] Zhejiang Univ, Dept Otolaryngol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
[3] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
apigenin; head and neck; adenoid cystic carcinoma; glucose transporter-1; anticancer effect; PANCREATIC-CANCER CELLS; LARYNGEAL CARCINOMA; INDUCED APOPTOSIS; NECK CANCERS; CYCLE ARREST; EXPRESSION; PATHWAY; HEAD; GLUT-1; CHEMOPREVENTION;
D O I
10.3892/mmr.2015.4233
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apigenin is a natural phyto-oestrogen flavonoid, which exerts various biological effects, including anti-oxidative, anti-inflammatory and anticancer activities. In addition, apigenin has recently been reported to target hypoxic markers; however, there are currently no studies regarding the association between apigenin and glucose transporter-1 (GLUT-1) in adenoid cystic carcinoma (ACC). The present study investigated whether apigenin inhibits the proliferation of ACC cells or suppresses the expression of GLUT-1 in ACC cells. The results of the present study demonstrated that apigenin inhibits ACC-2 cell growth in a dose- and time-dependent manner. Treatment with apigenin also induced apoptosis and G(2)/M-phase arrest in a dose- and time-dependent manner. Corresponding with the above results, the expression levels of GLUT-1 were significantly decreased following treatment in a dose- and time-dependent manner. These results suggest that the inhibition of ACC-2 cell growth by apigenin may be due to the decreased expression of GLUT-1.
引用
收藏
页码:6461 / 6466
页数:6
相关论文
共 24 条
  • [11] Clinical Significance of FDG Single-Photon Emission Computed Tomography: Computed Tomography in the Diagnosis of Head and Neck Cancers and Study of Its Mechanism
    Li, Ling-Fa
    Zhou, Shui-Hong
    Zhao, Kui
    Wang, Shen-Qing
    Wu, Qiu-Liang
    Fan, Jun
    Cheng, Ke-Jia
    Ling, Ling
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (06) : 701 - 714
  • [12] Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: Implication of chemoprevention of lung cancer
    Liu, LZ
    Fang, J
    Zhou, Q
    Hu, XW
    Shi, XL
    Jiang, BH
    [J]. MOLECULAR PHARMACOLOGY, 2005, 68 (03) : 635 - 643
  • [13] Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells
    Liu, Tian-Qi
    Fan, Jun
    Zhou, Lin
    Zheng, Shu-Sen
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (01) : 72 - 77
  • [14] Apigenin Down-Regulates the Hypoxia Response Genes: HIF-1α, GLUT-1, and VEGF in Human Pancreatic Cancer Cells
    Melstrom, Laleh G.
    Salabat, Mohammad R.
    Ding, Xian-Zhong
    Strouch, Matthew J.
    Grippo, Paul J.
    Mirzoeva, Salida
    Pelling, Jill C.
    Bentrem, David J.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) : 173 - 181
  • [15] Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells
    Melstrom, Laleh G.
    Salabat, Mohammad R.
    Ding, Xian-Zhong
    Milam, Benjamin M.
    Strouch, Matthew
    Pelling, Jill C.
    Bentrem, David J.
    [J]. PANCREAS, 2008, 37 (04) : 426 - 431
  • [16] Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2
    Oishi, Masakatsu
    Iizumi, Yosuke
    Taniguchi, Tomoyuki
    Goi, Wakana
    Miki, Tsuneharu
    Sakai, Toshiyuki
    [J]. PLOS ONE, 2013, 8 (02):
  • [17] CHEMOTHERAPY AND TARGETED THERAPY IN ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK: A REVIEW
    Papaspyrou, Giorgos
    Hoch, Stephan
    Rinaldo, Alessandra
    Rodrigo, Juan P.
    Takes, Robert P.
    van Herpen, Carla
    Werner, Jochen A.
    Ferlito, Alfio
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (06): : 905 - 911
  • [18] Patel D, 2007, INT J ONCOL, V30, P233
  • [19] Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells
    Shukla, Sanjeev
    Gupta, Sanjay
    [J]. CELL CYCLE, 2007, 6 (09) : 1102 - 1114
  • [20] Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma
    Wu, Xiao-Hong
    Chen, Su-Ping
    Mao, Jian-Ying
    Ji, Xue-Xian
    Yao, Hong-Tian
    Zhou, Shui-Hong
    [J]. ONCOLOGY LETTERS, 2013, 5 (01) : 261 - 266